All In MedTech

Device Trial Radar · NCT04987138

Safety and Effectiveness Study of the Zenflow Spring System

Safety and Effectiveness Study of the Zenflow Spring System - A Minimally Invasive Treatment for LUTS Associated With BPH

Last checked: Nov 19, 2026Latest source record: Apr 11, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 279 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

279

Planned (sponsor's estimate)

Start

Sep 30, 2021

Primary completion

Jun 30, 2024

Study completion Jun 2026

Sponsor

Lead sponsor
Zenflow, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Aug 3, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Triple (participant, care provider, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Male only, from 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Evaluate the safety and effectiveness of the Zenflow Spring System in relieving LUTS associated with BPH.

Conditions

  • BPH (Benign Prostatic Hyperplasia)
  • Lower Urinary Tract Symptoms (LUTS)

Interventions

  • Zenflow Spring SystemDevice

    The Zenflow Spring Implant is an electropolished and passivated nickel titanium alloy (nitinol) implant. The implant is constructed from a single wire strand formed into ring elements connected by spine sections. There are four sizes of implants ranging from 16 mm to 24 mm in length and 14 mm to 16 mm in diameter to implant in the subject's prostatic urethra. The implant is placed in the urethra using a custom delivery catheter and cystoscope (Spring Scope). The implant is intended to be permanent but can be removed if necessary.

  • Sham ProcedureDevice

    A18 Fr Foley Catheter is placed into the patient's bladder. To mimic the Treatment Arm procedure, the Foley Catheter balloon will be inflated in the bladder. Once inflated, slight tension will be applied against the subject's bladder neck. While tension is being applied the site staff will follow a script to simulate the Zenflow procedural steps. Additionally, devices will be used to produce mock deployment sounds of the Zenflow procedure. Once complete, the balloon will be deflated and the catheter will be removed, completing the procedure.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety - The need for urinary catheterizationTime frame: Greater than 7 days after procedure
  2. Safety - Adverse EventsTime frame: Procedure through 12 months
  3. Effectiveness of the Spring Implant in reducing symptoms of Benign Prostatic Hyperplasia (BPH) as compared to ShamTime frame: Procedure to 3 months

1 more outcomes with a free account

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • American Institute of Research

    Los Angeles, California

  • Northshore University Health System

    Glenview, Illinois

  • Sheldon Freedman, MD, LTD

    Las Vegas, Nevada

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.